Risk screening for HPV after LEEP
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how to sort people into higher- or lower-risk groups after abnormal HPV testing treatment (LEEP), using repeat HPV and Pap (cytology) tests. It may help improve follow-up plans by identifying who needs closer monitoring after LEEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive HPV screening result and be in the 50–64 age range.
- You need follow-up testing 6 months after a LEEP procedure done in Denmark (Central Denmark Region), using HPV and Pap (cytology).
- You need another follow-up test 12 months after LEEP, using HPV and Pap (cytology).
- Your study records must include a valid “cytology triage” result.
- You must not be listed as someone who rejected research participation in the study registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether getting the HPV vaccine after a LEEP (a procedure to remove abnormal cervical cells) can help prevent the abnormal cells from coming back. It's for women who have had high-grade cervical changes or very early cervical cancer.
This study looks at how a common cervical procedure called LEEP affects your sexual health and quality of life. It follows women who need a LEEP for the first time to see how they feel afterward.
This study tests a new questionnaire that may help doctors better identify which women need treatment for cervical changes. It is for women who have had an abnormal Pap smear or a positive HPV test and are going for a colposcopy (a closer look at the cervix).
This early (Phase 1) study tests a new treatment for people with long-lasting mild abnormal Pap test results (ASC-US or LSIL) who also have HPV16 found on testing. It aims to find out whether the treatment can be given safely and may affect the HPV and abnormal cell changes.
This study tests if a self-collected sample for HPV testing works as well as standard colposcopy to prevent cervical cancer. If you've recently had an abnormal cervical cancer screening and need a colposcopy, this trial may be an option for you.
This trial studies a blood test that looks for HPV DNA after cervical cancer surgery. The test may help doctors predict if the cancer might come back and decide if more treatment is needed.
Hear when a new Cervix Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.